1. Audentes Appoints To Board Of Directors

    Audentes Appoints To Board Of Directors

    Audentes Therapeutics, Inc. (Nasdaq: BOLD), a biotechnology company focused on developing and commercializing gene therapy products for patients living with serious, life-threatening rare diseases, today announced the appointment of Julie Anne Smith to its board of directors. "We are delighted to welcome Julie to our board of directors," stated Matthew Patterson , President and Chief Executive Officer.

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content
  2. Quotes

    1. We are delighted to welcome Julie to our board of directors.
  3. Topics Mentioned